Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study ; day:15 ; month:04 ; year:2024
South Asian journal of cancer ; (15.04.2024)
- Contributor
-
Simhadri, Soumya
Dayyala, Sowmya
Musinipally, Anjani Devi
Guram, Lavanya
Madavi, Mamatha
Kancha, Ramakrishna
Puligundla, Krishna Chaitanya
- DOI
-
10.1055/s-0044-1786001
- URN
-
urn:nbn:de:101:1-2406061102323.947049836804
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Simhadri, Soumya
- Dayyala, Sowmya
- Musinipally, Anjani Devi
- Guram, Lavanya
- Madavi, Mamatha
- Kancha, Ramakrishna
- Puligundla, Krishna Chaitanya
Other Objects (12)
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Acupuncture Point Selection Patterns for Chemotherapy-Induced Nausea and Vomiting: A Data Mining Analysis
Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Acupuncture Point Selection Patterns for Chemotherapy-Induced Nausea and Vomiting: A Data Mining Analysis
Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Acupuncture Point Selection Patterns for Chemotherapy-Induced Nausea and Vomiting: A Data Mining Analysis
Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience